CClinicalTrials.gg
Status unknownNCT05145777ACSUpdated Dec 15, 2021

Patients Returning to Work After Acute Coronary Syndrome

An observational study in Acute Coronary Syndrome, sponsored by University Hospital, Strasbourg, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-15.

Sponsored by University Hospital, Strasbourg, France · Observational

The sponsor has not verified this record recently (last verified Nov 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
40
Ages
18 Years and older
Sex
All
01

Study summary

The literature is quite rich concerning the factors which influence the return to work after acute coronary syndrome. They can be divided into three categories: factors linked to the patient, those linked to the workstation and factors linked to an external intervention. A study published in 1992 evaluated a set of predictive factors for recovery one year after acute coronary syndrome and showed that the proportion of clinical factors accounted for 20%, functional factors for 27% but above all socio-economic factors for 45. %.

On the other hand, there are only a few studies that are interested in the return to work after acute coronary syndrome according to the management in occupational medicine, and in particular the realization or not of a pre-return visit.

The results of a survey published in 2016 show that the recommendations made during the return visit were significantly different depending on whether or not there was a pre-return visit and concerned all types of pathology.

In view of all of these elements, it seems important to the investigators to study the expected benefit of an early orientation towards occupational medicine via the pre-return visit, and to study the factors delaying or favoring the return to work. .

02

Conditions studied

  • Acute Coronary Syndrome

Keywords

  • Acute Coronary Syndrome
  • ACS
  • Return to work
  • Occupational health
  • Cardiology
  • Intensive-care unit
03

In context

Acute Coronary Syndrome

1,461 studies on the registry are indexed under Acute Coronary Syndrome; 267 are open to participants now.

This study's planned enrollment of 40 is below the median of 500 across 561 observational studies indexed under Acute Coronary Syndrome.

Browse Acute Coronary Syndrome studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult subject in professional activity during acute coronary syndrome

Inclusion criteria

  • Age ≥18 years old
  • In professional activity during acute coronary syndrome (employee, civil servant, self-employed or looking for a job)
  • -Mastering the French language (knowing how to read and write French)
  • Agreeing to participate in the study and not having expressed his opposition to the reuse of his data for the purposes of this research

Exclusion criteria

Exclusion criteria:

  • Subject having expressed opposition to participating in the study
  • Inability to provide informed information about the subject (subject in an emergency situation, difficulty in understanding the subject, etc.)
  • Subject under safeguard of justice
  • Subject under guardianship or guardianship
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Study of the contribution of the pre-return visit to the return to work after acute coronary syndrome

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
  • Service de Pathologie Professionnelle - Médecine de Travail - Hôpitaux Universitaires de Strasbourg
    Strasbourg, 67091, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 15, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05145777
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Dec 6, 2021
Start date
Jul 30, 2021
Primary completion
Jun 2022 (estimated)
Completion
Jun 2022 (estimated)
Last update
Dec 15, 2021

Study contacts

Marc André GOLTZENE, MD
Contact
marcandre.goltzene@chru-strasbourg.fr
33 3 88 11 64 66
Saïd CHAYER, PhD, HDR
Contact
said.chayer@chru-strasbourg.fr
Marc André GOLTZENE, MD
principal investigator · Service de Pathologie Professionnelle - Médecine de Travail - Hôpitaux Universitaires de Strasbourg

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion